WO2014195534A1 - Method for selecting specific antibodies of european hake (merluccius merluccius) for assigning individuals to the populations thereof according to whether they are of atlantic origin or mediterranean origin - Google Patents

Method for selecting specific antibodies of european hake (merluccius merluccius) for assigning individuals to the populations thereof according to whether they are of atlantic origin or mediterranean origin Download PDF

Info

Publication number
WO2014195534A1
WO2014195534A1 PCT/ES2014/000038 ES2014000038W WO2014195534A1 WO 2014195534 A1 WO2014195534 A1 WO 2014195534A1 ES 2014000038 W ES2014000038 W ES 2014000038W WO 2014195534 A1 WO2014195534 A1 WO 2014195534A1
Authority
WO
WIPO (PCT)
Prior art keywords
origin
merluccius
individuals
atlantic
antibodies
Prior art date
Application number
PCT/ES2014/000038
Other languages
Spanish (es)
French (fr)
Inventor
Elena Guacimara GONZÁLEZ JIMÉNEZ
José Manuel BAUTISTA SANTA CRUZ
Original Assignee
Universidad Complutense De Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Complutense De Madrid filed Critical Universidad Complutense De Madrid
Publication of WO2014195534A1 publication Critical patent/WO2014195534A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Definitions

  • the present invention relates to specific antibodies against hake ⁇ Merluccius merluccius) as discrimination tools for their populations according to their origin (Mediterranean or Atlantic basin).
  • the evaluation of said discriminant capacity is based on the quantitative analysis of the levels of expression of the antigens of samples of hake individuals captured in both basins against said antibodies.
  • the invention can be used in diagnostic analysis format based on immunodetection techniques.
  • European Union European Union
  • European hake (Merluccius mer ⁇ uccius, Linnaeus, 1758) constitutes a species of high fishing interest within the EU and is exploited for fishing throughout its distribution.
  • European hake is geographically distributed from the western Atlantic Ocean (approximately 62 ° N, near the Shetland Islands, including the Norwegian fjords, up to 23 ° N in Mauritania) to the Mediterranean Sea.
  • microsatellites constitute the most used molecules as traceability tools and for the analysis of genetic diversity and determination of the structuring of hake populations. Studies based on the use of these markers have been able to differentiate two genetically different stocks or populations of hake, one corresponding to the Atlantic Ocean and another to the Mediterranean Sea, with the contact area located on the coast near Almeria and Oran (Lundy et al., 1999, Molecular Ecology 8: 1889-1898). But nevertheless, microsatellites have calibration and reproducibility limitations between laboratories and are not usually used as a control instrument.
  • the present invention relates to a method of selection and subsequent application of specific European hake antibodies (Mer ⁇ uccius mer ⁇ uccius) as tools of discrimination of their populations according to their origin (Mediterranean or Atlantic basin), by immunodetection techniques.
  • European hake antibodies Mer ⁇ uccius mer ⁇ uccius
  • proteins with different levels of expression are identified, using specific polyclonal antibodies against peptides present in the proteins in question of this species. Subsequently, based on the statistical analysis of expression levels, it is possible to classify a hake sample as coming from the Atlantic region or the Mediterranean region.
  • a method is presented in which different criteria for peptide selection are applied, which are subsequently used for the production of specific antibodies against Mer ⁇ uccius mer ⁇ uccius.
  • the use of several criteria in the selection of the peptides that have served as antigens in this invention has led to obtaining results with a power of discrimination far superior to the use of these same criteria separately.
  • the method includes the analysis of the protein expression of European hake tissues or organs in individuals from the Atlantic Ocean and in individuals from the Mediterranean Sea.
  • those proteins whose levels of expression are different in individuals from the Atlantic Ocean with respect to individuals from the Mediterranean Sea have been selected and these proteins have been identified.
  • the organ used has been the brain and the selected proteins have been: the ATP synthetase protein, a 60 kDa alpha subunit, characterized by SEQ ID NO: 1; 14-3-3 28 kDa protein, characterized by SEQ ID NO: 2; and the 30 kDa voltage-dependent anion channel protein, characterized by SEQ ID NO: 3. From these proteins, the amino acid sequences that are predicted as constituents of transmembrane a-helix segments exposed to the matrix have been identified. extracellular and specific antibodies have been produced against the amino acid sequences of said extracellular segments.
  • the method may include the addition of 1 or 2 amino acids and / or molecules to the selected peptides, in order to increase their immunogenic capacity.
  • the invention also includes combinations of specific European hake antibodies to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin that include one or more antibodies generated according to the method just described. These combinations may include one or more of the specific antibodies generated against the peptides characterized by SEQ ID NO: 4, SEQ ID NO: 5 and / or SEQ ID NO: 6 which, in addition, may include 1 or 2 amino acids and / or molecules, with the aim of increasing their immunogenic capacity.
  • a method of classifying hake protein extract samples in Atlantic or Mediterranean populations comprises the detection and quantification of antigens corresponding to proteins of the Merluccius merluccius species, by immunodetection techniques from of the antibodies generated in the present invention, and the quantification of the expression levels of the corresponding proteins.
  • the analysis of the expression levels for each protein turns out to be significantly different and characteristic of Mediterranean or Atlantic populations.
  • the immunodetection techniques comprising the invention may be immunoenzymatic techniques (such as the ELISA technique), immunofluorescence (such as the FPIA technique), immunoblot techniques (such as the Westernblot technique) and agglutination techniques (such as the DAT or FAST technique ) or any other method based on the detection of antigens.
  • immunoenzymatic techniques such as the ELISA technique
  • immunofluorescence such as the FPIA technique
  • immunoblot techniques such as the Westernblot technique
  • agglutination techniques such as the DAT or FAST technique
  • the invention includes a kit for assigning European hake individuals ⁇ Merluccius merluccius) to their populations according to whether they are of Atlantic origin or of Mediterranean origin by means of an immunodetection method in which at least one of the antibodies produced against the peptides characterized by SEQ ID NO: 4, 5 and / or 6 or against these peptides which, in addition, include 1 or 2 amino acids and / or molecules, in order to increase their immunogenic capacity.
  • an immunodetection method in which at least one of the antibodies produced against the peptides characterized by SEQ ID NO: 4, 5 and / or 6 or against these peptides which, in addition, include 1 or 2 amino acids and / or molecules, in order to increase their immunogenic capacity.
  • Figure 1 10% SDS polyacrylamide gel corresponding to the purified antibodies obtained against SEQ ID NO: 4, 5 and 6 (lanes 2-4, respectively) and to the unpurified antibodies obtained against SEQ ID NO: 4, 5 and 6 (lanes 6-8, respectively). Lane 1 corresponds to the standard protein size (Bio-Rad. No. Ref 161-0318). Approximately 40 ⁇ g of each antibody was loaded into each lane.
  • Figure 2 Separation of protein extracts by 10% polyacrylamide-SDS gel and immunodetection by generated antisera. Representative bands are shown that correspond to the migration size of the protein from which the peptide used as an antigen has been selected. All bands were analyzed, but only some representative ones are shown for each of the five sampled populations. ATL: individuals from the Atlantic Ocean populations. MED: individuals from the Mediterranean Sea populations. Lines 1, 2 and 3 correspond to the three different antibodies tested.
  • Figure 3 "Box plot” graph of the statistical analysis of the quantitative values of proteins detected in "Western” immunoblotting. The average statistical value of the analytical signal (represented by a black line), the upper and lower quartiles and the outliers are also indicated.
  • A, C and E correspond to individuals from the Atlantic Ocean populations.
  • B, D and F correspond to individuals from the Mediterranean Sea populations.
  • Lines 1, 2 and 3 correspond to the three types of antibodies tested.
  • Example 1 The present invention is further illustrated by the following examples, which are not intended to be limiting in scope.
  • Example 1 The present invention is further illustrated by the following examples, which are not intended to be limiting in scope.
  • MALDI-TOF MS mass spectrometry analysis
  • MALDI- TOF / TOF generated peptides or peptide fingerprint (“mass fingerprint”), and peptides or amino acid sequences (with a +1 charge) with a signal-to-noise ratio greater than 10 were collected and grouped into a list of monoisotopic molecular weights , filtering the rest of the peaks using the GPS Explorer v3.6 program (Applied Biosystems, Framingham, MA).
  • the resulting peptide footprint was compared with the expected peptide masses for each available entry in the NCBI database specific to fish protein sequences (consisting of 257,377 sequences and 83,362,140 residues as of September 25, 2009), using the MASCOT v2.1 (Matrix Science) program.
  • ATP synthetase protein 60 kDa alpha subunit (NCBI accession number: gi
  • the amino acid sequences that had the greatest exposure to the extracellular matrix were chosen.
  • the HMMTOP v2.0 program was used, which is able to predict the transmembrane topology of proteins from their complete amino acid sequence (Tusnády and Simón, 2001, Bioinformatics, 17 (9): 849-850).
  • EAYPGDVFYLHSR characterized by SEQ ID NO: 4, internal fragment (334-347) of SEQ ID NO: 1,
  • AVTEQGAELSNEER characterized by SEQ ID NO: 5, internal fragment (27-41) of SEQ ID NO: 2,
  • VNNSSLVGLGYTQTLKPGIK characterized by SEQ ID NO: 6, internal fragment (236-256) of SEQ ID NO: 3.
  • the numbers in parentheses refer to the residues of the sequence deduced from the cDNA, as they appear in the corresponding sequences.
  • the peptides selected according to example 1 were commissioned to synthesize the company Mimotopes (Mimotopes Pty. Ltd., Clayton, Victoria, Australia). The resulting peptides were purified by HPLC. To obtain a stronger immune response, a cysteine residue (C) was added during the synthesis at the N-terminal end of the peptides, which was used to conjugate them with a barnacle hemocyanin molecule (KLH) by binding with maleimide . These peptides thus prepared were used as antigens in the process of immunization and production of polyclonal antibodies described below.
  • the complete Freund's adjuvant (AFC) was used only in the first immunization, where 300 ng of the emulsion prepared above was administered intradermally to each female rabbit.
  • the AFC was replaced by Freund's incomplete adjuvant (AIF).
  • AIF Freund's incomplete adjuvant
  • three weeks after the first immunization three other administrations were performed every two weeks at a lower concentration (200 ng).
  • Blood samples were collected before and after immunizations. The extracted blood was left at room temperature for 3-4 hours, after which it was centrifuged at 3000 rpm for 15 minutes at 4 ° C to separate the sera. In this way, six heterologous sera (containing the antibodies) were isolated from the rest of the blood fractions, and subsequently stored at -20 ° C.
  • the antibodies thus obtained were purified using the Spin Nab kit (Pierce Biotechnology, Inc.), following the supplier's protocol.
  • the purified fraction of immunoglobilins-G (IgG) was analyzed by electrophoresis separation in gels from SDS-PAGE. The results indicated strong antibody production at the end of the immunization process.
  • a total of 72 hake brain samples were analyzed to determine the ability of the method to significantly assign individuals to each basin of origin (Atlantic or Mediterranean), using the antibodies generated according to example 2. Extraction of tissue proteins from Brain was carried out following the procedures previously described (González et al. 2010, Journal or Proteome Research, 9: 6392-6404). Brain samples of European hake from geographically remote regions were used, specifically from two regions in the Atlantic Ocean: the Bay of Biscay, (corresponding FAO area: 27.VIII.C) and the coast of Portugal, (FAO area: 27.
  • the composition of the loading buffer used was: 50 mM Tris-HCI, 5% SDS, 10% glycerol, 0.042% Bromophenol Blue and 5% 2'-mercaptoethanol, pH 6.8.
  • the samples were loaded on SDS-PAGE gels (at a concentration of 10%) and separated first at 70 mA for 30 minutes and then at 90 mA for one hour and twenty minutes, using a Bio-Rad transfer apparatus ( 1 mA / cm 2 for each gel).
  • the proteins thus separated were transferred to polyvinyl difluoride membranes (PVDF-Amersham Biosciences).
  • PVDF-Amersham Biosciences polyvinyl difluoride membranes
  • the composition of the transfer buffer used was: 50 mM NaCI, 2 mM Tris-HCI, pH 7.4.
  • the transfer of the proteins from the gel to the membrane was carried out at 150 mA for one hour and twenty minutes with a Bio-Rad transfer apparatus (1 mA / cm 2 for each gel). This process was carried out refrigerated (at 4 ° C) and using transfer buffer. Subsequently, the membranes (with the transferred proteins) were blocked by incubation with orbital shaking for one hour at room temperature in phosphate buffered saline (PBS) containing 5% skimmed milk powder (Central Lechera Asturiana).
  • PBS phosphate buffered saline
  • the antibodies used in Western blots, obtained according to example 2 were prepared at a dilution of 1: 1000, while the secondary antibody (anti-rabbit IgG, Amersham Biosciences) was used at a dilution of 1: 5000.
  • the blocked membranes were first incubated with each antibody of example 2 in PBS buffer containing 10% skimmed milk powder, overnight, with orbital shaking to 8 ° C The membranes were then washed by three serial incubations in PBS buffer containing 0.05% Tween, with orbital shaking, at room temperature for five minutes, and one last incubation in PBS buffer containing 0.05% Tween and 5% of skimmed milk powder, with orbital stirring at room temperature, for five minutes.
  • the secondary antibody anti-rabbit IgG was added and the membranes were incubated therewith for one hour at room temperature. Finally, the membranes were washed twice with orbital shaking at room temperature, for five minutes, with each of the following buffers consecutively: 1 o ) PBS buffer containing 0.05% Tween and 5% skimmed milk powder, 2 o ) PBS buffer containing 0.05% Tween; and 3 o ) PBS buffer.
  • the membranes thus prepared were revealed using the SuperSignal West Pico Rabbit IgG Detection (Thermo Scientific) detection kit by exposing sensitive photographic films that were subsequently scanned at high resolution.
  • protein 14-3-3 turned out to be a unique expression protein for individuals from the Mediterranean populations, which presented expression values, while in those of the Atlantic, said protein was either not expressed or did so at levels not detectable by its corresponding antibody.
  • the results indicate that the quantification values obtained with the antibodies make it possible to discriminate hake individuals by their basin of origin in a significant way.
  • Figure 3 graphically summarizes these results.

Abstract

The invention relates to a method for selecting peptides from proteins of tissues or organs of European hake in order to produce specific antibodies for identifying the origin of individual European hakes, assigning them to the Mediterranean basin or the Atlantic basin. Starting from the brain, peptides located in the following proteins are selected: ATP synthetase, subunit alpha; 14-3-3; and those of the voltage-dependent anion channel, respectively. The invention also relates to the combination of antibodies given the selected peptides, with which an immunodetection method has been designed in order to identify the populations of origin of the European hake. As well as the antibodies produced, the invention also relates to a kit for identifying the origin of the hakes.

Description

Título  Title
Método de selección de anticuerpos específicos de merluza europea (Merluccius merluccius) para asignar individuos a sus poblaciones según sean de origen Atlántico o de origen Mediterráneo Method of selection of specific European hake antibodies (Merluccius merluccius) to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin
Sector de la Técnica Technical Sector
La presente invención guarda relación con anticuerpos específicos frente a merluza {Merluccius merluccius) como herramientas de discriminación de sus poblaciones según su origen de procedencia (cuenca mediterránea o atlántica). La evaluación de dicha capacidad discriminante se basa en el análisis cuantitativo de los niveles de expresión de los antígenos de muestras de individuos de merluza capturados en ambas cuencas frente a dichos anticuerpos. La invención puede ser empleada en formato de análisis de diagnóstico basados en técnicas de inmunodetección.  The present invention relates to specific antibodies against hake {Merluccius merluccius) as discrimination tools for their populations according to their origin (Mediterranean or Atlantic basin). The evaluation of said discriminant capacity is based on the quantitative analysis of the levels of expression of the antigens of samples of hake individuals captured in both basins against said antibodies. The invention can be used in diagnostic analysis format based on immunodetection techniques.
Estado de la técnica State of the art
En la actualidad, existe un aumento en la necesidad de desarrollar herramientas de trazabilidad, tanto de pescados como de productos de pescado procesado, para la protección del consumidor final y como marco legal de trabajo para la aplicación de normativas y leyes que reduzcan la pesca ilegal, incontrolada y no regulada (IUU). Estas herramientas de trazabilidad no sólo se enfocan en determinar la especie de pescado sino también el origen de la captura. Así pues, pescados o productos de pescado procesado que estén mal etiquetados, en los cuales se indique de forma incorrecta el origen de pesca, suponen un efecto negativo indirecto en la gestión de las poblaciones o stocks de pesca, cuya consecuencia final puede constituir el agotamiento de sus recursos (Stokstad, E. 2010, Science, 330:1468-1469). En este contexto, la lucha contra la pesca IUU es una prioridad para la Unión Europea (UE), debido a la grave amenaza que representa globalmente para los ecosistemas marinos y la sostenibilidad de la pesca mundial. La merluza europea (Merluccius meríuccius, Linnaeus, 1758) constituye una especie de alto interés pesquero dentro de la UE y se explota para la pesca a lo largo de toda su distribución. La merluza europea está distribuida geográficamente desde el Océano Atlántico occidental (aproximadamente desde los 62°N, cerca de las islas Shetland, incluyendo los fiordos Noruegos, hasta los 23°N en Mauritania) hasta el Mar Mediterráneo. Currently, there is an increase in the need to develop traceability tools, both for fish and processed fish products, for the protection of the final consumer and as a legal framework for the application of regulations and laws that reduce illegal fishing , uncontrolled and unregulated (IUU). These traceability tools focus not only on determining the fish species but also the origin of the catch. Thus, fish or processed fish products that are mislabeled, in which the origin of fishing is incorrectly indicated, have an indirect negative effect on the management of fishing stocks or stocks, whose final consequence may constitute depletion of its resources (Stokstad, E. 2010, Science, 330: 1468-1469). In this context, the fight against IUU fishing is a priority for the European Union (EU), due to the serious threat it represents globally to marine ecosystems and the sustainability of global fisheries. European hake (Merluccius meríuccius, Linnaeus, 1758) constitutes a species of high fishing interest within the EU and is exploited for fishing throughout its distribution. European hake is geographically distributed from the western Atlantic Ocean (approximately 62 ° N, near the Shetland Islands, including the Norwegian fjords, up to 23 ° N in Mauritania) to the Mediterranean Sea.
La gestión de la explotación de las poblaciones de merluza europea es llevada a cabo por el Consejo Internacional para la Exploración del Mar (CIEM; en inglés, International Council fór the Exploration of the Seas, ICES) y la Comisión General de Pesca del Mediterráneo (CGPM; en inglés, General Fisheries Commission for the Mediterranean, GFCM). Dentro de la UE, España es el mayor productor de merluza, con más de 23.000 toneladas de capturas (FAO, 2012, FAO yearboo/r. Fisheries and Aquaculture Statistics 2010). Se considera que las poblaciones de merluza del Noroeste Atlántico se encuentran sobreexplotadas (Murua, 2010, Advances in Marine Biology, 58: 97-154). Es por ello que estas organizaciones han expresado la necesidad de mantener la biomasa de dichas poblaciones a un nivel que permita su explotación sostenible de acuerdo con el máximo rendimiento sostenible (ICES, www.ices.dk). Para ello resulta necesaria una correcta determinación del origen de las capturas que permita controlar el tráfico ilegal de las poblaciones. Los microsatélites constituyen las moléculas más utilizadas como herramientas de trazabilidad y para el análisis de diversidad genética y determinación de la estructuración de las poblaciones de merluza. Estudios basados en la utilización de estos marcadores han podido diferenciar a escala macro-geográfica dos stocks o poblaciones de merluza genéticamente diferentes, uno correspondiente al Océano Atlántico y otro al Mar Mediterráneo, con la zona de contacto situada en la costa cercana a Almería y Orán (Lundy et al., 1999, Molecular Ecology 8: 1889-1898). Sin embargo, los microsatélites presentan limitaciones de calibración y reproducibilidad entre laboratorios y no suelen utilizarse como instrumento de control. The management of the exploitation of European hake stocks is carried out by the International Council for the Exploration of the Sea (ICES; in English, the International Council for the Exploration of the Seas, ICES) and the General Fisheries Commission for the Mediterranean ( CGPM; in English, General Fisheries Commission for the Mediterranean, GFCM). Within the EU, Spain is the largest producer of hake, with more than 23,000 tonnes of catches (FAO, 2012, FAO yearboo / r. Fisheries and Aquaculture Statistics 2010). Hake populations in the Northwest Atlantic are considered to be overexploited (Murua, 2010, Advances in Marine Biology, 58: 97-154). That is why these organizations have expressed the need to maintain the biomass of these populations at a level that allows their sustainable exploitation in accordance with the maximum sustainable yield (ICES, www.ices.dk). For this, a correct determination of the origin of the catches is necessary to control the illegal traffic of the populations. The microsatellites constitute the most used molecules as traceability tools and for the analysis of genetic diversity and determination of the structuring of hake populations. Studies based on the use of these markers have been able to differentiate two genetically different stocks or populations of hake, one corresponding to the Atlantic Ocean and another to the Mediterranean Sea, with the contact area located on the coast near Almeria and Oran (Lundy et al., 1999, Molecular Ecology 8: 1889-1898). But nevertheless, microsatellites have calibration and reproducibility limitations between laboratories and are not usually used as a control instrument.
Con la caracterización de anticuerpos específicos de merluza europea capaces de asignar muestras de merluza con suficiente precisión mediante análisis por inmunoensayo, se abre un posible marco legal de trabajo para la aplicación de normativas y leyes que reduzcan la pesca IUU. Sin embargo, hasta la fecha no se ha descrito la existencia de estos anticuerpos ni su capacidad discriminatoria mediante una técnica de inmunoensayo. With the characterization of specific European hake antibodies capable of allocating hake samples with sufficient precision by immunoassay analysis, a possible legal framework for the application of regulations and laws that reduce IUU fishing is opened. However, to date the existence of these antibodies or their discriminatory capacity has not been described by means of an immunoassay technique.
Descripción detallada de la invención Detailed description of the invention
Método de selección de anticuerpos específicos de merluza europea (Meríuccius meríuccius) para asignar individuos a sus poblaciones según sean de origen Atlántico o de origen Mediterráneo  Method of selection of specific European hake antibodies (Meríuccius meríuccius) to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin
La presente invención se refiere a un método de selección y posterior aplicación de anticuerpos específicos de merluza europea (Meríuccius meríuccius) como herramientas de discriminación de sus poblaciones según su origen de procedencia (cuenca mediterránea o atlántica), mediante técnicas de inmunodetección. En extractos crudos de tejidos u órganos de merluza europea se identifican proteínas con diferente nivel de expresión, utilizando anticuerpos policlonales específicos frente a péptidos presentes en las proteínas en cuestión de esta especie. Posteriormente, en base al análisis estadístico de los niveles de expresión, es posible clasificar una muestra de merluza como procedente de la región atlántica o de la región mediterránea. The present invention relates to a method of selection and subsequent application of specific European hake antibodies (Meríuccius meríuccius) as tools of discrimination of their populations according to their origin (Mediterranean or Atlantic basin), by immunodetection techniques. In crude extracts of European hake tissues or organs, proteins with different levels of expression are identified, using specific polyclonal antibodies against peptides present in the proteins in question of this species. Subsequently, based on the statistical analysis of expression levels, it is possible to classify a hake sample as coming from the Atlantic region or the Mediterranean region.
En un primer aspecto de la invención se presenta un método en el que se aplican distintos criterios de selección de péptidos que, posteriormente, se utilizan para la producción de anticuerpos específicos frente a Meríuccius meríuccius. La utilización de varios criterios en la selección de los péptidos que han servido como antígenos en esta invención ha llevado a obtener resultados con un poder de discriminación muy superior a la utilización de esos mismos criterios por separado. In a first aspect of the invention a method is presented in which different criteria for peptide selection are applied, which are subsequently used for the production of specific antibodies against Meríuccius meríuccius. The use of several criteria in the selection of the peptides that have served as antigens in this invention has led to obtaining results with a power of discrimination far superior to the use of these same criteria separately.
En primer lugar, el método incluye el análisis de la expresión de proteínas de tejidos u órganos de merluza europea en individuos procedentes del Océano Atlántico y en individuos procedentes del Mar Mediterráneo. A continuación, se han seleccionado aquellas proteínas cuyos niveles de expresión son diferentes en los individuos procedentes del Océano Atlántico con respecto a los individuos procedentes del Mar Mediterráneo y se han identificado dichas proteínas. En una realización preferida de la invención, el órgano utilizado ha sido el cerebro y las proteínas seleccionadas han sido: la proteína ATP sintetasa, subunidad alfa de 60 kDa, caracterizada por SEQ ID NO: 1 ; la proteína 14-3-3 de 28 kDa, caracterizada por SEQ ID NO: 2; y la proteína de canal de aniones dependiente de voltaje de 30 kDa, caracterizada por SEQ ID NO: 3. A partir de estas proteínas se han identificado las secuencias de aminoácidos que se predicen como constituyentes de segmentos en a-hélice transmembrana expuestos a la matriz extracelular y se han producido anticuerpos específicos frente a las secuencias de aminoácidos de dichos segmentos extracelulares. First, the method includes the analysis of the protein expression of European hake tissues or organs in individuals from the Atlantic Ocean and in individuals from the Mediterranean Sea. Next, those proteins whose levels of expression are different in individuals from the Atlantic Ocean with respect to individuals from the Mediterranean Sea have been selected and these proteins have been identified. In a preferred embodiment of the invention, the organ used has been the brain and the selected proteins have been: the ATP synthetase protein, a 60 kDa alpha subunit, characterized by SEQ ID NO: 1; 14-3-3 28 kDa protein, characterized by SEQ ID NO: 2; and the 30 kDa voltage-dependent anion channel protein, characterized by SEQ ID NO: 3. From these proteins, the amino acid sequences that are predicted as constituents of transmembrane a-helix segments exposed to the matrix have been identified. extracellular and specific antibodies have been produced against the amino acid sequences of said extracellular segments.
De esta forma, se han determinado tres péptidos que se han utilizado para la producción de anticuerpos con capacidad de discriminación de las poblaciones de merluza europea. Estos péptidos están caracterizados por SEQ ID NO: 4, SEQ ID NO: 5 y SEQ ID NO: 6. In this way, three peptides have been determined that have been used for the production of antibodies capable of discriminating against European hake populations. These peptides are characterized by SEQ ID NO: 4, SEQ ID NO: 5 and SEQ ID NO: 6.
Así mismo, el método puede incluir la adición de 1 o 2 aminoácidos y/o moléculas a los péptidos seleccionados, con el objetivo de aumentar su capacidad inmunogénica. La invención también incluye combinaciones de anticuerpos específicos de merluza europea para asignar individuos a sus poblaciones según sean de origen Atlántico o de origen Mediterráneo que incluyen uno o más anticuerpos generados según el método que se acaba de describir. Estas combinaciones pueden incluir uno o varios de los anticuerpos específicos generados frente a los péptidos caracterizados por SEQ ID NO: 4, SEQ ID NO: 5 y/o SEQ ID NO: 6 que, además, pueden incluir 1 o 2 aminoácidos y/o moléculas, con el objetivo de aumentar su capacidad inmunogénica. Likewise, the method may include the addition of 1 or 2 amino acids and / or molecules to the selected peptides, in order to increase their immunogenic capacity. The invention also includes combinations of specific European hake antibodies to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin that include one or more antibodies generated according to the method just described. These combinations may include one or more of the specific antibodies generated against the peptides characterized by SEQ ID NO: 4, SEQ ID NO: 5 and / or SEQ ID NO: 6 which, in addition, may include 1 or 2 amino acids and / or molecules, with the aim of increasing their immunogenic capacity.
En otro aspecto de la invención, se presenta un método de clasificación de muestras de extracto proteico de merluza en poblaciones del Atlántico o del Mediterráneo que comprende la detección y cuantificación de antígenos correspondientes a proteínas de la especie Merluccius merluccius, mediante técnicas de inmunodetección a partir de los anticuerpos generados en la presente invención, y la cuantificación de los niveles de expresión de las correspondientes proteínas. Los análisis de los niveles de expresión para cada proteína resultan ser diferentes significativamente y característicos de poblaciones del Mediterráneo o del Atlántico. In another aspect of the invention, a method of classifying hake protein extract samples in Atlantic or Mediterranean populations is presented, which comprises the detection and quantification of antigens corresponding to proteins of the Merluccius merluccius species, by immunodetection techniques from of the antibodies generated in the present invention, and the quantification of the expression levels of the corresponding proteins. The analysis of the expression levels for each protein turns out to be significantly different and characteristic of Mediterranean or Atlantic populations.
Mediante la aplicación de técnicas de inmunodetección con los anticuerpos producidos frente a los péptidos caracterizados por SEQ ID NO: 4, SEQ ID NO: 5 y/o SEQ ID NO: 6 frente a los antígenos presentes en el cerebro de los individuos de merluza europea, se pueden asignar dichos individuos a sus poblaciones de origen según provengan del Atlántico o del Mediterráneo. By applying immunodetection techniques with antibodies produced against peptides characterized by SEQ ID NO: 4, SEQ ID NO: 5 and / or SEQ ID NO: 6 against antigens present in the brains of European hake individuals , these individuals can be assigned to their populations of origin as they come from the Atlantic or the Mediterranean.
Las técnicas de inmunodetección que comprende la invención pueden ser técnicas inmunoenzimáticas (como la técnica ELISA), de ¡nmunofluorescencia (como la técnica de FPIA), de inmunoblot (como la técnica de Westernblot) y de aglutinación (como la técnica de DAT o FAST) o cualquier otro método basado en la detección de antígenos. The immunodetection techniques comprising the invention may be immunoenzymatic techniques (such as the ELISA technique), immunofluorescence (such as the FPIA technique), immunoblot techniques (such as the Westernblot technique) and agglutination techniques (such as the DAT or FAST technique ) or any other method based on the detection of antigens.
Por otro lado, la invención incluye un kit para asignar individuos de merluza europea {Merluccius merluccius) a sus poblaciones según sean de origen Atlántico o de origen Mediterráneo mediante un método de inmunodetección en el que se incluye al menos uno de los anticuerpos producidos frente a los péptidos caracterizados por SEQ ID NO: 4, 5 y/o 6 o frente a estos péptidos que, además, incluyen 1 o 2 aminoácidos y/o moléculas, con el objetivo de aumentar su capacidad inmunogénica. Breve descripción de las figuras On the other hand, the invention includes a kit for assigning European hake individuals {Merluccius merluccius) to their populations according to whether they are of Atlantic origin or of Mediterranean origin by means of an immunodetection method in which at least one of the antibodies produced against the peptides characterized by SEQ ID NO: 4, 5 and / or 6 or against these peptides which, in addition, include 1 or 2 amino acids and / or molecules, in order to increase their immunogenic capacity. Brief description of the figures
Figura 1 : Gel de poliacrilamida-SDS al 10% correspondiente a los anticuerpos purificados obtenidos frente a SEQ ID NO: 4, 5 y 6 (carriles 2-4, respectivamente) y a los anticuerpos sin purificar obtenidos frente a SEQ ID NO: 4, 5 y 6 (carriles 6-8, respectivamente). El carril 1 corresponde al tamaño estándar de proteínas (Bio-Rad. N° Ref 161-0318). Se cargaron en cada carril aproximadamente 40 μg de cada anticuerpo. Figure 1: 10% SDS polyacrylamide gel corresponding to the purified antibodies obtained against SEQ ID NO: 4, 5 and 6 (lanes 2-4, respectively) and to the unpurified antibodies obtained against SEQ ID NO: 4, 5 and 6 (lanes 6-8, respectively). Lane 1 corresponds to the standard protein size (Bio-Rad. No. Ref 161-0318). Approximately 40 μg of each antibody was loaded into each lane.
Figura 2: Separación de los extractos de proteína mediante gel de poliacrilamida-SDS al 10% e inmunodetección mediante los antisueros generados. Se muestran bandas representativas que corresponden con el tamaño de migración de la proteína de la que se ha seleccionado el péptido usado como antígeno. Todas las bandas fueron analizadas, pero solo se muestran algunas representativas para cada una de las cinco poblaciones muestreadas. ATL: individuos de las poblaciones del Océano Atlántico. MED: individuos de las poblaciones del Mar Mediterráneo. Líneas 1 , 2 y 3 corresponde a los tres diferentes anticuerpos testados. Figure 2: Separation of protein extracts by 10% polyacrylamide-SDS gel and immunodetection by generated antisera. Representative bands are shown that correspond to the migration size of the protein from which the peptide used as an antigen has been selected. All bands were analyzed, but only some representative ones are shown for each of the five sampled populations. ATL: individuals from the Atlantic Ocean populations. MED: individuals from the Mediterranean Sea populations. Lines 1, 2 and 3 correspond to the three different antibodies tested.
Figura 3: Gráfica "box plot" del análisis estadístico de los valores cuantitativos de proteínas detectados en inmunotransferencias "Western". El valor estadístico medio de la señal analítica (representada por una línea negra), los cuartiles superiores e inferiores y los "outliers" también están indicados. A, C y E corresponden a individuos de las poblaciones del Océano Atlántico. B, D y F corresponden a individuos de las poblaciones del Mar Mediterráneo. Líneas 1 , 2 y 3 corresponden a los tres tipos de anticuerpos testados. Modo de realización de la invención Figure 3: "Box plot" graph of the statistical analysis of the quantitative values of proteins detected in "Western" immunoblotting. The average statistical value of the analytical signal (represented by a black line), the upper and lower quartiles and the outliers are also indicated. A, C and E correspond to individuals from the Atlantic Ocean populations. B, D and F correspond to individuals from the Mediterranean Sea populations. Lines 1, 2 and 3 correspond to the three types of antibodies tested. Embodiment of the invention
La presente invención se ilustra adicionalmente mediante los siguientes ejemplos, los cuales no pretenden ser limitativos de su alcance. Ejemplo 1  The present invention is further illustrated by the following examples, which are not intended to be limiting in scope. Example 1
Selección de las secuencias de aminoácidos  Selection of amino acid sequences
Se siguieron dos criterios distintos de selección de las secuencias de aminoácidos utilizados para la producción de los anticuerpos. Por un lado, se seleccionaron las proteínas que presentaban mayor capacidad de discriminación entre poblaciones (es decir, aquellas que presentaban mayores niveles de expresión diferencial a nivel estadístico). Posteriormente, de estas proteínas se seleccionaron aquellos péptidos o secuencias de aminoácidos que mediante análisis predictivo presentaban exposición en la matriz extracelular. Así, 35 bandas o manchas ("spots") de proteínas procedentes de cerebro de merluza fueron seleccionadas mediante análisis de la variación en su expresión comparando muestras procedentes de distintas poblaciones geográficas y analizándolas mediante 2D/DIGE y espectrometría de masas, de un total de 145 proteínas (González et al. 2010, Journal or Proteome Research, 9: 6392-6404). Una vez seleccionadas estas 35 proteínas, se identificaron mediante análisis de espectrometría de masas (MALDI-TOF MS). Los análisis de MALDI-TOF MS se realizaron en un espectrómetro de masas tipo 4800 Proteomics Analyzer MALDI-TOF/TOF (Applied Biosystems, Framingham, MA), operando en modo reflector de ión positivo con un voltaje de aceleración de 20000 V. MALDI-TOF/TOF generó péptidos o huella peptídica ("mass fingerprint"), y los péptidos o secuencias de aminoácidos (con una carga +1) con una relación señal-ruido mayor de 10 se recogieron y se agruparon en una lista de pesos moleculares monoisotópicos, filtrando el resto de los picos mediante el programa GPS Explorer v3.6 (Applied Biosystems, Framingham, MA). A fin de identificar las proteínas, la huella peptídica resultante se comparó con las masas peptídicas esperadas para cada entrada disponible en la base de datos del NCBI específica de secuencias proteínicas de peces (constituida por 257.377 secuencias y 83.362.140 residuos a fecha de 25 de Septiembre de 2009), utilizando el programa MASCOT v2.1 (Matrix Science). De las 35 proteínas con niveles significativos de expresión se seleccionaron estadísticamente mediante la Función Discriminante de Fisher, aquellas tres proteínas con capacidad discriminante de más del 90%. De esta forma, se seleccionaron: la proteína ATP sintetasa, subunidad alfa de 60 kDa (número de acceso del NCBI: gi|223648354; SEQ ID NO: 1 , secuencia de aminoácidos correspondiente a la proteína ATP sintetasa subunidad alfa de la especie Salmo salar); la proteína 14-3-3 de 28 kDa (número de acceso del NCBI: gi|50844461 ; SEQ ID NO: 2, secuencia de aminoácidos correspondiente a la proteína 14-3-3 de la especie Oreochromis mossambicus) y proteína de canal de aniones dependiente de voltaje de 30 kDa (número de acceso del NCBI: gi| 169642540; SEQ ID NO: 3, secuencia de aminoácidos correspondiente a la proteína de canal de aniones dependiente de voltaje de la especie Salmo sa^. Two different criteria for selecting the amino acid sequences used for the production of the antibodies were followed. On the one hand, the proteins that presented the greatest capacity for discrimination among populations were selected (that is, those with the highest levels of differential expression at the statistical level). Subsequently, from these proteins, those peptides or amino acid sequences were selected which, by predictive analysis, exhibited exposure in the extracellular matrix. Thus, 35 bands or spots ("spots") of proteins from hake brain were selected by analysis of the variation in their expression comparing samples from different geographic populations and analyzing them using 2D / DIGE and mass spectrometry, from a total of 145 proteins (González et al. 2010, Journal or Proteome Research, 9: 6392-6404). Once these 35 proteins were selected, they were identified by mass spectrometry analysis (MALDI-TOF MS). MALDI-TOF MS analyzes were performed on a 4800 Proteomics Analyzer MALDI-TOF / TOF (Applied Biosystems, Framingham, MA) mass spectrometer, operating in positive ion reflector mode with an acceleration voltage of 20,000 V. MALDI- TOF / TOF generated peptides or peptide fingerprint ("mass fingerprint"), and peptides or amino acid sequences (with a +1 charge) with a signal-to-noise ratio greater than 10 were collected and grouped into a list of monoisotopic molecular weights , filtering the rest of the peaks using the GPS Explorer v3.6 program (Applied Biosystems, Framingham, MA). In order to identify the proteins, the resulting peptide footprint was compared with the expected peptide masses for each available entry in the NCBI database specific to fish protein sequences (consisting of 257,377 sequences and 83,362,140 residues as of September 25, 2009), using the MASCOT v2.1 (Matrix Science) program. Of the 35 proteins with significant levels of expression, those three proteins with discriminant capacity of more than 90% were statistically selected using Fisher's Discriminant Function. Thus, the following were selected: ATP synthetase protein, 60 kDa alpha subunit (NCBI accession number: gi | 223648354; SEQ ID NO: 1, amino acid sequence corresponding to the ATP synthetase protein alpha subunit of Salmo salar species ); 14-3-3 28 kDa protein (NCBI accession number: gi | 50844461; SEQ ID NO: 2, amino acid sequence corresponding to protein 14-3-3 of the Oreochromis mossambicus species) and channel protein 30 kDa voltage-dependent anions (NCBI accession number: gi | 169642540; SEQ ID NO: 3, amino acid sequence corresponding to the voltage-dependent anion channel protein of the Salmo sa ^ species.
Como segundo criterio de selección, a partir de las proteínas antes identificadas, se escogieron las secuencias de aminoácidos que presentaban mayor exposición a la matriz extracelular. Para ello se utilizó el programa HMMTOP v2.0, que es capaz de predecir la topología transmembrana de las proteínas a partir de su secuencia completa de aminoácidos (Tusnády y Simón, 2001 , Bioinformatics, 17 (9): 849-850). As the second selection criteria, from the proteins identified above, the amino acid sequences that had the greatest exposure to the extracellular matrix were chosen. For this, the HMMTOP v2.0 program was used, which is able to predict the transmembrane topology of proteins from their complete amino acid sequence (Tusnády and Simón, 2001, Bioinformatics, 17 (9): 849-850).
Como resultado, se seleccionaron tres regiones de secuencia de aminoácidos o péptidos: As a result, three amino acid or peptide sequence regions were selected:
1) EAYPGDVFYLHSR, caracterizado por SEQ ID NO: 4, fragmento interno (334-347) de SEQ ID NO: 1 ,  1) EAYPGDVFYLHSR, characterized by SEQ ID NO: 4, internal fragment (334-347) of SEQ ID NO: 1,
2) AVTEQGAELSNEER, caracterizado por SEQ ID NO: 5, fragmento interno (27-41 ) de SEQ ID NO: 2,  2) AVTEQGAELSNEER, characterized by SEQ ID NO: 5, internal fragment (27-41) of SEQ ID NO: 2,
3) VNNSSLVGLGYTQTLKPGIK, caracterizado por SEQ ID NO: 6, fragmento interno (236-256) de SEQ ID NO: 3. Los números entre paréntesis se refieren a los residuos de la secuencia deducida a partir del cDNA, tal y como aparecen en las secuencias correspondientes. Ejemplo 2 3) VNNSSLVGLGYTQTLKPGIK, characterized by SEQ ID NO: 6, internal fragment (236-256) of SEQ ID NO: 3. The numbers in parentheses refer to the residues of the sequence deduced from the cDNA, as they appear in the corresponding sequences. Example 2
Producción y purificación de los anticuerpos policlonales  Production and purification of polyclonal antibodies
Los péptidos seleccionados según el ejemplo 1 se encargaron para sintetizar a la compañía Mimotopes (Mimotopes Pty. Ltd., Clayton, Victoria, Australia). Los péptidos resultantes se purificaron por HPLC. Para obtener una respuesta inmune más fuerte, se añadió durante la síntesis un residuo de cisteína (C) en el extremo N-terminal de los péptidos, que fue utilizado para conjugarlos con una molécula de hemocianina de lapa (KLH) mediante la unión con maleimida. Estos péptidos así preparados fueron usados como antígenos en el proceso de inmunización y producción de anticuerpos policlonales que se describe a continuación. The peptides selected according to example 1 were commissioned to synthesize the company Mimotopes (Mimotopes Pty. Ltd., Clayton, Victoria, Australia). The resulting peptides were purified by HPLC. To obtain a stronger immune response, a cysteine residue (C) was added during the synthesis at the N-terminal end of the peptides, which was used to conjugate them with a barnacle hemocyanin molecule (KLH) by binding with maleimide . These peptides thus prepared were used as antigens in the process of immunization and production of polyclonal antibodies described below.
El experimento al completo se llevó a cabo en las instalaciones de la Universidad Complutense de Madrid (UCM), y se siguieron las directrices del Consejo Científico Internacional de Animales de Laboratorio. Seis conejos hembra de la raza New Zeland White (NZW) se compraron con un peso medio de 2.5-3.5 kilogramos a la granja San Bernardo (Navarra, España), libres de enfermedades. Se mantuvieron en los animalarios de la UCM con acceso libre y continuado a comida y agua. Para la primera inmunización, se hizo una mezcla (dilución 1 :1) con el péptido (disuelto en tampón fosfato salino -PBS- a una concentración de 1 mg) y el adyuvante de Freund completo (Sigma). Cada péptido se inoculó en dos animales para obtener dos réplicas de un mismo anticuerpo. El adyuvante de Freund completo (AFC) se utilizó únicamente en la primera inmunización, donde 300 ng de la emulsión antes preparada fueron administrados de forma intradérmica a cada conejo hembra. En las siguientes inmunizaciones, el AFC fue sustituido por el adyuvante incompleto de Freund (AIF). Así pues, tres semanas después de la primera inmunización, se realizaron otras tres administraciones cada dos semanas a una concentración menor (200 ng). Las muestras de sangre se recogieron antes y después de las inmunizaciones. La sangre extraída se dejó a temperatura ambiente durante 3-4 horas, transcurridas las cuales se centrifugó a 3000 rpm durante 15 minutos a 4°C para separar los sueros. De esta forma, se aislaron seis sueros heterólogos (que contenían los anticuerpos) del resto de las fracciones de sangre, y, posteriormente, se conservaron a -20°C. The entire experiment was carried out at the facilities of the Complutense University of Madrid (UCM), and the guidelines of the International Scientific Council of Laboratory Animals were followed. Six female rabbits of the New Zeland White (NZW) breed were purchased with an average weight of 2.5-3.5 kilograms from the farm San Bernardo (Navarra, Spain), disease free. They were kept at the UCM's animarians with free and continued access to food and water. For the first immunization, a mixture (1: 1 dilution) was made with the peptide (dissolved in phosphate buffered saline -PBS- at a concentration of 1 mg) and the complete Freund's adjuvant (Sigma). Each peptide was inoculated into two animals to obtain two replicates of the same antibody. The complete Freund's adjuvant (AFC) was used only in the first immunization, where 300 ng of the emulsion prepared above was administered intradermally to each female rabbit. In the following immunizations, the AFC was replaced by Freund's incomplete adjuvant (AIF). Thus, three weeks after the first immunization, three other administrations were performed every two weeks at a lower concentration (200 ng). Blood samples were collected before and after immunizations. The extracted blood was left at room temperature for 3-4 hours, after which it was centrifuged at 3000 rpm for 15 minutes at 4 ° C to separate the sera. In this way, six heterologous sera (containing the antibodies) were isolated from the rest of the blood fractions, and subsequently stored at -20 ° C.
Con el fin de evitar interacciones inespecíficas en los análisis inmunoquímicos posteriores, los anticuerpos así obtenidos fueron purificados utilizando el kit Spin Nab (Pierce Biotechnology, Inc.), siguiendo el protocolo del proveedor. La fracción purificada de inmunoglobilinas-G (IgG) se analizó mediante separación por electroforesis en geles de SDS-PAGE. Los resultados indicaron una fuerte producción de anticuerpos al final del proceso de inmunización. In order to avoid nonspecific interactions in subsequent immunochemical analyzes, the antibodies thus obtained were purified using the Spin Nab kit (Pierce Biotechnology, Inc.), following the supplier's protocol. The purified fraction of immunoglobilins-G (IgG) was analyzed by electrophoresis separation in gels from SDS-PAGE. The results indicated strong antibody production at the end of the immunization process.
Este proceso de purificación puede verse resumido en la Figura 1. This purification process can be summarized in Figure 1.
Ejemplo 3 Example 3
Detección de los anticuerpos por "western blot" Western blot antibody detection
Se analizaron un total de 72 muestras de cerebro de merluza para determinar la capacidad del método para asignar de forma significativa individuos a cada cuenca de origen (atlántica o mediterránea), utilizando los anticuerpos generados según el ejemplo 2. La extracción de proteínas de tejido de cerebro se llevó a cabo siguiendo los procedimientos descritos previamente (González et al. 2010, Journal or Proteome Research, 9: 6392-6404). Se utilizaron muestras de cerebro de merluza europea de regiones alejadas geográficamente, concretamente de dos regiones en el Océano Atlántico: el Golfo de Vizcaya, (área FAO correspondiente: 27.VIII.C) y la costa de Portugal, (área FAO: 27.IX.a); y otras tres en el Mar Mediterráneo: Mar Egeo, (área FAO: 37.1.1), Mar Adriático, (área FAO: 37.2.1) y costa de Cerdeña, (área FAO: 37.1.3). Todas las muestras fueron capturadas en el mismo período del año 2008. A total of 72 hake brain samples were analyzed to determine the ability of the method to significantly assign individuals to each basin of origin (Atlantic or Mediterranean), using the antibodies generated according to example 2. Extraction of tissue proteins from Brain was carried out following the procedures previously described (González et al. 2010, Journal or Proteome Research, 9: 6392-6404). Brain samples of European hake from geographically remote regions were used, specifically from two regions in the Atlantic Ocean: the Bay of Biscay, (corresponding FAO area: 27.VIII.C) and the coast of Portugal, (FAO area: 27. IX.a); and three others in the Mediterranean Sea: Aegean Sea, (FAO area: 37.1.1), Adriatic Sea, (FAO area: 37.2.1) and Sardinia coast, (FAO area: 37.1.3). All samples were captured in the same period of 2008.
Se utilizaron 80 μg de proteina total extraída de cada uno de los 72 individuos que se mezclaron con tampón de carga para geles SDS-PAGE y se calentaron a 100°C durante 5 minutos. La composición del tampón de carga utilizado fue: Tris-HCI 50 mM, SDS 5%, glicerol 10%, Azul de Bromofenol 0,042% y 2'-mercaptoetanol 5%, pH 6.8. Las muestras se cargaron en geles SDS-PAGE (a una concentración del 10%) y se separaron primero a 70 mA durante 30 minutos y, después, a 90 mA durante una hora y veinte minutos, utilizando un aparato de transferencia Bio-Rad (1 mA/cm2 por cada gel). Posteriormente, las proteínas así separadas fueron transferidas a membranas de difluoruro de polivinilo (PVDF-Amersham Biosciences). Para ello, el gel de poliacrilamida y la membrana se equilibraron previamente en tampón de transferencia, con agitación orbital durante 15 minutos. La composición del tampón de transferencia utilizado fue: 50 mM NaCI, 2 mM Tris-HCI, pH 7.4. 80 μg of total protein extracted from each of the 72 individuals that were mixed with loading buffer for SDS-PAGE gels were used and heated at 100 ° C for 5 minutes. The composition of the loading buffer used was: 50 mM Tris-HCI, 5% SDS, 10% glycerol, 0.042% Bromophenol Blue and 5% 2'-mercaptoethanol, pH 6.8. The samples were loaded on SDS-PAGE gels (at a concentration of 10%) and separated first at 70 mA for 30 minutes and then at 90 mA for one hour and twenty minutes, using a Bio-Rad transfer apparatus ( 1 mA / cm 2 for each gel). Subsequently, the proteins thus separated were transferred to polyvinyl difluoride membranes (PVDF-Amersham Biosciences). For this, the polyacrylamide gel and the membrane were previously equilibrated in transfer buffer, with orbital agitation for 15 minutes. The composition of the transfer buffer used was: 50 mM NaCI, 2 mM Tris-HCI, pH 7.4.
La transferencia de las proteínas del gel a la membrana se llevó a cabo a 150 mA durante una hora y veinte minutos con un aparato de transferencia Bio- Rad (1 mA/cm2 por cada gel). Este proceso se realizó de forma refrigerada (a 4°C) y empleando tampón de transferencia. Posteriormente, las membranas (con las proteínas transferidas) fueron bloqueadas mediante incubación con agitación orbital durante una hora a temperatura ambiente en tampón fosfato salino (PBS) que contenía 5% de leche en polvo desnatada (Central Lechera Asturiana). The transfer of the proteins from the gel to the membrane was carried out at 150 mA for one hour and twenty minutes with a Bio-Rad transfer apparatus (1 mA / cm 2 for each gel). This process was carried out refrigerated (at 4 ° C) and using transfer buffer. Subsequently, the membranes (with the transferred proteins) were blocked by incubation with orbital shaking for one hour at room temperature in phosphate buffered saline (PBS) containing 5% skimmed milk powder (Central Lechera Asturiana).
Los anticuerpos usados en las inmunotransferencias Western, obtenidos según el ejemplo 2, se prepararon a una dilución de 1 :1000, mientras que el anticuerpo secundario (IgG anti-conejo, Amersham Biosciences) se utilizó a una dilución de 1 :5000. Así pues, las membranas bloqueadas se incubaron primero con cada anticuerpo del ejemplo 2 en tampón PBS que contenía 10% de leche en polvo desnatada, durante toda la noche, con agitación orbital a 8°C. A continuación, las membranas se lavaron mediante tres incubaciones seriadas en tampón PBS que contenía 0,05% Tween, con agitación orbital, a temperatura ambiente durante cinco minutos, y una última incubación en tampón PBS que contenía 0,05% Tween y 5% de leche en polvo desnatada, con agitación orbital a temperatura ambiente, durante cinco minutos. Después de los lavados, se añadió el anticuerpo secundario (IgG anti-conejo) y se incubaron las membranas con el mismo durante una hora a temperatura ambiente. Finalmente, las membranas se lavaron dos veces con agitación orbital a temperatura ambiente, durante cinco minutos, con cada uno de los siguientes tampones consecutivamente: 1o) tampón PBS que contenía 0,05 % Tween y 5% de leche en polvo desnatada, 2o) tampón PBS que contenía 0,05% Tween; y 3o) tampón PBS. The antibodies used in Western blots, obtained according to example 2, were prepared at a dilution of 1: 1000, while the secondary antibody (anti-rabbit IgG, Amersham Biosciences) was used at a dilution of 1: 5000. Thus, the blocked membranes were first incubated with each antibody of example 2 in PBS buffer containing 10% skimmed milk powder, overnight, with orbital shaking to 8 ° C The membranes were then washed by three serial incubations in PBS buffer containing 0.05% Tween, with orbital shaking, at room temperature for five minutes, and one last incubation in PBS buffer containing 0.05% Tween and 5% of skimmed milk powder, with orbital stirring at room temperature, for five minutes. After washing, the secondary antibody (anti-rabbit IgG) was added and the membranes were incubated therewith for one hour at room temperature. Finally, the membranes were washed twice with orbital shaking at room temperature, for five minutes, with each of the following buffers consecutively: 1 o ) PBS buffer containing 0.05% Tween and 5% skimmed milk powder, 2 o ) PBS buffer containing 0.05% Tween; and 3 o ) PBS buffer.
Las membranas así preparadas se revelaron usando el kit de detección SuperSignal West Pico Rabbit IgG Detection (Thermo Scientific) mediante la exposición de películas fotográficas sensibles que, posteriormente, se escanearon a alta resolución. The membranes thus prepared were revealed using the SuperSignal West Pico Rabbit IgG Detection (Thermo Scientific) detection kit by exposing sensitive photographic films that were subsequently scanned at high resolution.
Los resultados indicaron la existencia de bandas de reacción de anticuerpos de tamaño correspondiente al peso molecular de la proteína de origen, es decir, que los anticuerpos obtenidos presentaban una reactividad específica a los antígenos correspondientes. Además, el patrón de expresión resultó ser diferente según la población geográfica muestreada. El resultado de este proceso puede verse resumido en la Figura 2. The results indicated the existence of antibody reaction bands of size corresponding to the molecular weight of the protein of origin, that is, the antibodies obtained had a specific reactivity to the corresponding antigens. In addition, the expression pattern turned out to be different according to the sampled geographic population. The result of this process can be summarized in Figure 2.
Ejemplo 4 Example 4
Cuantifícación de la señal para cada anticuerpo  Signal quantification for each antibody
Cada película fotográfica fue escaneada (escáner modelo EPSON PERFECTION V750 PRO) a una resolución de 300 d.p.i. La señal de expresión de cada proteína para cada inmunoensayo (medido como el área para cada banda detectada) se cuantificó utilizando el software ImageJ (versión 1.44). El valor absoluto de cada medida se expresó en porcentaje respecto a la medida de valor más alto dentro de cada "Western". Los valores de expresión para cada anticuerpo fueron estadísticamente analizados para determinar posibles correlaciones entre niveles de expresión y regiones geográficas de procedencia de las muestras. Para los análisis de T de Student se agruparon las muestras pertenecientes a cuencas del Atlántico, por un lado, y del Mediterráneo, por otro, y se estableció un nivel de significación ("p-value") inferior a 0,05. Según los resultados, la proteína ATP sintetasa subunidad alfa presentó niveles de expresión significativamente diferentes entre individuos capturados en el Océano Atlántico o en el Mar Mediterráneo (T de Student, t = 5.70, p = 0.023, df = 66), siendo las poblaciones del Atlántico las que mostraron mayor sobreexpresión de dicha proteína. En cambio, la proteína 14-3-3 resultó ser una proteína de expresión única para los individuos de las poblaciones del Mediterráneo, los cuales presentaron valores de expresión, mientras que en los del Atlántico dicha proteína bien no se expresó o bien lo hizo a niveles no detectables por su correspondiente anticuerpo. Finalmente, la proteína de canal de aniones dependiente de voltaje presentó niveles de expresión significativamente diferentes entre individuos capturados en el Océano Atlántico o en el Mar Mediterráneo (T de Student, t = 7.06, p = 0.000, df = 55), siendo en este caso las poblaciones del Mediterráneo las que mostraron mayor sobreexpresión de dicha proteína. Los resultados indican que los valores de cuantificación obtenidos con los anticuerpos permiten discriminar individuos de merluza por su cuenca de origen de forma significativa. La Figura 3 resume de forma gráfica estos resultados. Each photographic film was scanned (EPSON PERFECTION V750 PRO model scanner) at a resolution of 300 dpi The expression signal of each protein for each immunoassay (measured as the area for each band detected) was quantified using ImageJ software (version 1.44). The absolute value of each measurement was expressed as a percentage of the highest value measurement within each "Western". Expression values for each antibody were statistically analyzed to determine possible correlations between expression levels and geographic regions of sample origin. For the Student's T analyzes, the samples belonging to the Atlantic basins, on the one hand, and the Mediterranean, on the other, were grouped and a significance level ("p-value") of less than 0.05 was established. According to the results, the ATP synthetase alpha subunit protein presented significantly different levels of expression among individuals captured in the Atlantic Ocean or in the Mediterranean Sea (Student's T, t = 5.70, p = 0.023, df = 66), being the populations of the Atlantic those that showed greater overexpression of said protein. On the other hand, protein 14-3-3 turned out to be a unique expression protein for individuals from the Mediterranean populations, which presented expression values, while in those of the Atlantic, said protein was either not expressed or did so at levels not detectable by its corresponding antibody. Finally, the voltage-dependent anion channel protein showed significantly different levels of expression among individuals captured in the Atlantic Ocean or in the Mediterranean Sea (Student's T, t = 7.06, p = 0.000, df = 55), being in this In this case, the Mediterranean populations showed the highest overexpression of said protein. The results indicate that the quantification values obtained with the antibodies make it possible to discriminate hake individuals by their basin of origin in a significant way. Figure 3 graphically summarizes these results.

Claims

REIVINDICACIONES
1 . Método de selección de anticuerpos específicos de merluza europea (Merluccius merluccius) para asignar individuos a sus poblaciones según sean de origen Atlántico o de origen Mediterráneo que incluye: one . Method of selection of specific European hake antibodies (Merluccius merluccius) to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin that includes:
a) analizar la expresión de proteínas de merluza europea en tejidos u órganos de individuos procedentes del Océano Atlántico y de individuos procedentes del Mar Mediterráneo, a) analyze the expression of European hake proteins in tissues or organs of individuals from the Atlantic Ocean and individuals from the Mediterranean Sea,
b) seleccionar las proteínas del paso a) cuyos niveles de expresión son diferentes en los individuos procedentes del Océano Atlántico con respecto a los individuos procedentes del Mar Mediterráneo, b) select the proteins from step a) whose levels of expression are different in individuals from the Atlantic Ocean with respect to individuals from the Mediterranean Sea,
c) identificar las proteínas seleccionadas en el paso b), c) identify the proteins selected in step b),
d) en las proteínas identificadas en c), identificar las secuencias de aminoácidos que constituyen segmentos en α-hélice transmembrana expuestos a la matriz extracelular; d) in the proteins identified in c), identify the amino acid sequences that constitute segments in transmembrane α-helix exposed to the extracellular matrix;
e) producir anticuerpos específicos frente a las secuencias de aminoácidos identificadas en d), utilizando péptidos sintéticos. e) produce specific antibodies against the amino acid sequences identified in d), using synthetic peptides.
2. Método según la reivindicación 1 en el que el órganos seleccionado para realizar el paso a) es el cerebro. 2. Method according to claim 1 wherein the organs selected to perform step a) is the brain.
3. Método según cualquiera de las reivindicaciones 1 -2 en el que los péptidos del paso e) incluyen 1 o 2 aminoácidos y/o moléculas que aumentan su capacidad inmunogénica. 3. Method according to any of claims 1-2 in which the peptides of step e) include 1 or 2 amino acids and / or molecules that increase their immunogenic capacity.
4. Combinación de anticuerpos específicos de merluza europea (Merluccius merluccius) para asignar individuos a sus poblaciones según sean de origen Atlántico o de origen Mediterráneo que incluye uno o más anticuerpos seleccionados según el método definido en cualquiera de las reivindicaciones 1 -3. 4. Combination of specific European hake antibodies (Merluccius merluccius) to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin that includes one or more antibodies selected according to the method defined in any of claims 1-3.
5. Combinación de anticuerpos según la reivindicación 4 en la que uno de los anticuerpos incluidos se une específicamente a un péptido cuya secuencia de aminoácidos es SEQ ID NO: 4. 5. Antibody combination according to claim 4 wherein one of the included antibodies specifically binds to a peptide whose amino acid sequence is SEQ ID NO: 4.
6. Combinación de anticuerpos según cualquiera de las reivindicaciones 4-5 en la que uno de los anticuerpos incluidos se une específicamente a un péptido cuya secuencia de aminoácidos es SEQ ID NO: 5. 6. Antibody combination according to any of claims 4-5 wherein one of the included antibodies specifically binds to a peptide whose amino acid sequence is SEQ ID NO: 5.
7. Combinación de anticuerpos según cualquiera de las reivindicaciones 4-6 en la que uno de los anticuerpos incluidos se une específicamente a un péptido cuya secuencia de aminoácidos es SEQ ID NO: 6. 7. Antibody combination according to any of claims 4-6 wherein one of the included antibodies specifically binds to a peptide whose amino acid sequence is SEQ ID NO: 6.
8. Combinación de anticuerpos según cualquiera de las reivindicaciones 4-7 en la que las secuencias de aminoácidos incluyen una cisteína en el extremo N-terminal y una molécula de hemocianina de lapa (KLH) conjugada mediante unión con maleimida. 8. Antibody combination according to any of claims 4-7 wherein the amino acid sequences include a cysteine at the N-terminal end and a lapa hemocyanin molecule (KLH) conjugated by maleimide binding.
9. Método de inmunodetección para asignar individuos de merluza europea (Merluccius merluccius) a sus poblaciones según sean de origen Atlántico o de origen Mediterráneo, que se basa en una técnica seleccionada del grupo que comprende: técnicas inmunoenzimáticas (como la técnica ELISA), de inmunofluorescencia (como la técnica de FPIA), de inmunoblot (como la técnica de Westernblot) y de aglutinación (como la técnica de DAT o FAST) o cualquier otro método basado en la detección de antígenos y que incluye la utilización de combinaciones de anticuerpos según se definen en las reivindicaciones 4-8 frente a antígenos presentes en el cerebro de los individuos de merluza europea. 9. Immunodetection method to assign European hake individuals (Merluccius merluccius) to their populations according to whether they are of Atlantic origin or of Mediterranean origin, which is based on a technique selected from the group comprising: immunoenzymatic techniques (such as the ELISA technique), of immunofluorescence (such as the FPIA technique), immunoblot (such as the Westernblot technique) and agglutination (such as the DAT or FAST technique) or any other method based on the detection of antigens and that includes the use of antibody combinations according to They are defined in claims 4-8 against antigens present in the brains of European hake individuals.
10. Kit para asignar individuos de merluza europea (Merluccius merluccius) a sus poblaciones según sean de origen Atlántico o de origen Mediterráneo mediante un método según se define en la reivindicación 9, que incluye una combinación de anticuerpos según se definen en las reivindicaciones 4-8. 10. Kit for assigning European hake individuals (Merluccius merluccius) to their populations as being of Atlantic origin or of Mediterranean origin by a method as defined in claim 9, which includes a combination of antibodies as defined in claims 4- 8.
PCT/ES2014/000038 2013-06-07 2014-03-14 Method for selecting specific antibodies of european hake (merluccius merluccius) for assigning individuals to the populations thereof according to whether they are of atlantic origin or mediterranean origin WO2014195534A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201300539A ES2526468B2 (en) 2013-06-07 2013-06-07 Method of selection of specific antibodies of European hake (Merluccius merluccius) to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin.
ESP201300539 2013-06-07

Publications (1)

Publication Number Publication Date
WO2014195534A1 true WO2014195534A1 (en) 2014-12-11

Family

ID=52007600

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2014/000038 WO2014195534A1 (en) 2013-06-07 2014-03-14 Method for selecting specific antibodies of european hake (merluccius merluccius) for assigning individuals to the populations thereof according to whether they are of atlantic origin or mediterranean origin

Country Status (2)

Country Link
ES (1) ES2526468B2 (en)
WO (1) WO2014195534A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003087831A2 (en) * 2002-04-11 2003-10-23 Oxford Glycosciences (Uk) Ltd Proteins involved in breast cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003087831A2 (en) * 2002-04-11 2003-10-23 Oxford Glycosciences (Uk) Ltd Proteins involved in breast cancer

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CARRERA, M. ET AL.: "Discrimination of south african comercial fish species (Merluccius capensis and Merluccius paradoxus) by LC-MS/MS analysis of the protein aldolase''.", JOURNAL OF AQUATIC FOOD PRODUCT TECHNOLOGY., vol. 18, no. 1-2, 24 March 2009 (2009-03-24), pages 67 - 78 *
CASTILLO, A.G.F. ET AL.: "Fine spatial structure of atlantic hake (Merluccius merluccius) stocks revealed by variation at microsatellite loci.", MARINE BIOTECHNOLOGY., vol. 6, no. 4, August 2004 (2004-08-01), pages 299 - 306 *
FORNÉ, I. ET AL.: "Fish proteome analysis: model organisms and non-sequenced species.", PROTEOMICS, vol. 10, no. 4, February 2010 (2010-02-01), pages 858 - 872 *
GONZÁLEZ, E.G. ET AL.: "Population proteomics of the european hake (Merluccius merluccius).", JOURNAL OF PROTEOME RESERCH., vol. 9, no. 12, pages 6392 - 6404 *
ROLDÁN, M.I. ET AL.: "Population genetic structure of European hake, Merluccius merluccius''.", HEREDITY., vol. 81, no. 3, September 1998 (1998-09-01), pages 327 - 334 *

Also Published As

Publication number Publication date
ES2526468B2 (en) 2015-08-07
ES2526468A1 (en) 2015-01-12

Similar Documents

Publication Publication Date Title
ES2734226T3 (en) Methods, devices, kits and compositions for detecting whip worms
US9068007B2 (en) Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
JP2007333744A (en) Method for identifying existence of antibody against intracellular protein antigen, and specific intracellular protein antigen within serum
ES2805085T3 (en) Glypican Epitopes and Uses of These
Cantillo et al. Identification and characterization of IgE-binding tropomyosins in Aedes aegypti
ES2702534T3 (en) Test kit for the titration of antibodies in plasma or serum against bacteria that cause periodontal diseases
US20130251749A1 (en) Methods and compositions for chlamydial antigens as reagents/strategies for diagnosis and treatment of chlamydial infection and disease
ES2526468B2 (en) Method of selection of specific antibodies of European hake (Merluccius merluccius) to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin.
Gil et al. Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: a road map for discovering new antigens
WO2015097654A1 (en) Synthetic peptides, method and kit for immunodiagnosis of canine visceral leishmaniasis, and human cutaneous and visceral leishmaniasis
BR102014013193A2 (en) Method and Kit for Diagnosing Leishmaniasis Using Synthetic Peptides Derived from the Mitogen-Activated Protein Kinase 3 Encoding Gene (Putative)
BR102014004107B1 (en) method and kit for the diagnosis of leishmaniasis using synthetic peptides
JP4364433B2 (en) A novel peptide-based assay for the diagnosis of schizophrenia
Whyte et al. Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system
Zienkiewicz et al. Identification of olive pollen allergens using a fluorescence‐based 2D multiplex method
KR101776922B1 (en) Anti-ikaros polyclonal antibodies with serine 391/393 phosporylation and use thereof as indicator of specific property due to low level radiation(low dose ionizing radiation) exposure
Ribeiro et al. Neurocysticercosis serodiagnosis: mimotope-based synthetic peptide as potential biomarker
CN109517049A (en) Application of the LINC00266-1 polypeptide as entity tumor markers
Udonsom et al. Immunoproteomics to identify species-specific antigens in Neospora caninum recognised by infected bovine sera
WO2008066483A1 (en) Use of nalp5 in methods for diagnosis and therapy of parathyroid related disorders
KR20130005088A (en) Protein marker rpe-spondin for colon cancer diagnosis and diagnosis kit for colon cancer using antibodies against the same
US8741594B2 (en) Mitochondrial enoyl coenzyme A hydratase 1 as marker for diagnosing stomach cancer
US8372412B2 (en) Bioassay and peptides for use therein
CN101556278B (en) A kind of method of screening autoantigen
CN106191022B (en) A kind of tumour specific antigen and its application

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14808421

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14808421

Country of ref document: EP

Kind code of ref document: A1